Privia Health Group Sells: CFO Signals Tax Strategy
When a top executive unloads stock, it signals more than a simple liquidity move. This article breaks down Privia Hea...
Healthcare Stocks
This tag page curates 5 Healthcare Stocks articles to help you assess risks, dividend potential, and notable moves from Chemed to UnitedHealth, helping smarter investment decisions.
95 articles
This $6.5 Million Healthcare Move Drives Investor Signals
A notable fund trimmed a sizable healthcare stake by roughly $6.5 million as the stock soared and revenue grew. Here’...
Is Down Near 5-Year Low a Cheap Novo Nordisk Stock?
Novo Nordisk has drifted toward a five-year low, raising questions about value vs. risk. This guide breaks down the f...
Molina Healthcare Stock Falls: Is It a Buy Now?
A major fund just increased its stake in Molina Healthcare, while the stock trades lower. This guide breaks down what...
Healthcare Stock Rebound 2026: Opportunities Align
A powerful, data-driven case for why the healthcare stock rebound 2026 is more than a rumor. Learn how to spot streng...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
This Promising GLP-1 Drug Could Renew Novo Nordisk Hope
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Is There Much Bullishness Priced Into Eli Lilly Stock?
Eli Lilly has enjoyed rapid growth from GLP-1 drugs, but sky-high expectations invite questions about valuations. Thi...
Cigna: Which Healthcare Giant Fits Your Retirement Portfolio
In a turbulent 2026 market, CVS Health and Cigna are at the center of retirement portfolio debates. This piece weighs...
Care Giant Posts $5.1 Billion Revenue, Investor Grows Stake
A premier eye care company delivers $5.1 billion in revenue, while a prominent investor quietly expands holdings. Her...
Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Related Topics
#Investing (71)
#Stock Analysis (20)
#Stock Market (17)
#Dividend Investing (8)
#Portfolio Strategy (6)
#Dividend Stocks (6)
#UnitedHealth (6)
#Earnings Analysis (6)
#Portfolio Management (5)
#Earnings (5)
#Novo Nordisk (5)
#Biotech Investing (5)
#Pfizer (5)
#Income Investing (4)
#Johnson & Johnson (4)